Regístrese
¿Aún no está registrado?
Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta
Buscar en
Allergologia et Immunopathologia
Toda la web
Inicio Allergologia et Immunopathologia Cross-over clinical trial for evaluating the safety of camel's milk intake i...
Journal Information
Share
Share
Download PDF
More article options
ePub
Visits
11
Original Article
DOI: 10.1016/j.aller.2017.06.005
Cross-over clinical trial for evaluating the safety of camel's milk intake in patients who are allergic to cow's milk protein
Visits
11
E.M. Navarrete-Rodrígueza, L.A. Ríos-Villalobosa, C.R. Alcocer-Arreguína, B.E. Del-Rio-Navarroa,
Corresponding author
blancadelrionavarro@gmail.com

Corresponding author.
, J.M. Del Rio-Chivardia, O.J. Saucedo-Ramíreza, J.J.L. Sienra-Mongeb, R.V. Friasc
a Department of Allergy and Clinical Immunology, Hospital Infantil de México Federico Go??mez, Ciudad de México, Mexico
b Department of Ambulatory Pediatrics, Hospital Infantil de México Federico Go??mez, Ciudad de México, Mexico
c Department of Gastroenterology and Nutrition, Hospital Infantil de México Federico Go??mez, Ciudad de México, Mexico
This item has received
11
Visits
Received 24 March 2017, Accepted 21 June 2017
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (4)
Table 1. Nutritional composition of 100ml of camel milk and other milk formulas.25–27
Table 2. Steps for administration of double-blind placebo-controlled oral challenge.
Table 3. Description of the population included in the study in groups: camel milk and amino-acid formula.
Table 4. Symptoms presented in patients with DBPCFC positive to cow's milk.
Show moreShow less
Abstract
Background

Cow's milk protein allergy (CMPA) affects between 0.6 and 0.9% of the general population, and its treatment implies the total elimination of the intake of this protein. Camel's milk has been suggested as an alternative for patients over one year of age who suffer from CMPA due to the difference in the amino acid sequence from that of cow's milk. The objective of this study was to evaluate the safety and tolerability of camel's milk in children with CMPA.

Methods

Crossed clinical trial for the use of camel's milk vs. amino acid formula, carried out at the Dr. Federico Gómez Children's Hospital of Mexico (HIMFG) on patients between one and 18 years of age with diagnosed CMPA confirmed through double-blind, placebo-controlled food challenges (DBPCFCs). Only those whose allergies were confirmed were randomly placed into two groups: those to be administered camel's milk and those to be administered the amino-acid formula for two weeks, followed by a six-week wash-out period, and then a group crossing for a further two weeks.

Results

49 patients with suspected CMPA were included in the study; the diagnosis was confirmed through DBPCFCs in 15 patients, who were those who participated in the study. After having been administered camel's milk, none of the patients presented adverse effects.

Conclusions and clinical relevance

Camel's milk is safe and tolerable in patients above one year of age with CMPA and can be considered as a good alternative given the benefit of its taste compared to other formulas.

Keywords:
Cow's milk protein allergy (CMPA)
Camel milk
Abbreviations:
CMPA
HIMFG
DBPCFC

Article

These are the options to access the full texts of the publication Allergologia et Immunopathologia
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Allergologia et Immunopathologia

Contact
Telephone
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
902 88 87 40
Calls from outside Spain
+34 932 418 800
E-mail
es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos